Subha Madhavan
Pfizer (United States)(US)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Genomics and Rare Diseases, Pancreatic and Hepatic Oncology Research, Cancer, Lipids, and Metabolism, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer(2016)1,090 cited
- → Proteogenomic Analysis of Human Colon Cancer Reveals New Therapeutic Opportunities(2019)819 cited
- → The CPTAC Data Portal: A Resource for Cancer Proteomics Research(2015)576 cited
- → Proteogenomic Landscape of Breast Cancer Tumorigenesis and Targeted Therapy(2020)532 cited
- → Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial(2020)527 cited
- → Rembrandt: Helping Personalized Medicine Become a Reality through Integrative Translational Research(2009)426 cited
- → Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative(2018)257 cited
- → Standards for the classification of pathogenicity of somatic variants in cancer (oncogenicity): Joint recommendations of Clinical Genome Resource (ClinGen), Cancer Genomics Consortium (CGC), and Variant Interpretation for Cancer Consortium (VICC)(2022)217 cited
- → The REMBRANDT study, a large collection of genomic data from brain cancer patients(2018)215 cited
- → A harmonized meta-knowledgebase of clinical interpretations of somatic genomic variants in cancer(2020)174 cited